|
|
By Kathleen Warner, Ph.D., RCM Technologies
This article takes a closer look at AI and intelligent technologies in biotech, medical devices, and pharma, and what we can expect to tackle in 2022 and beyond. The article also identifies some of the new concerns and challenges with disruptive technologies and risk management, and also discusses a technology and generation timeline.
|